Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label duloxetine extension after HMDG trial completion
2004-001237-42Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Jun 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2004-001237-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001237-42.